title: Transdifferentiated rat pancreatic progenitor cells (AR42J-B13/H) respond to phenobarbital in a rat hepatocyte-specific manner.
abstract: Phenobarbital (PB) is known to produce species-specific effects in the rat and mouse, being carcinogenic in certain mouse strains, but only in rats if treated after a DNA damaging event. PB treatment in the rat and mouse also produces disparate effects on cell signalling and miRNA expression profiles. These responses are induced by short term and prolonged PB exposure, respectively, with the latter treatments being difficult to examine mechanistically in primary hepatocytes due to rapid loss of the original hepatic phenotype and limited sustainability in culture. Here we explore the rat hepatocyte-like B13/H cell line as a model for hepatic response to PB exposure in both short-term and longer duration treatments. We demonstrate that PB with Egf treatment in the B13/H cells resulted in a significant increase in Erk activation, as determined by the ratio of phospho-Erk to total Erk, compared to Egf alone. We also show that an extended treatment with PB in the B13/H cells produces a miRNA response similar to that seen in the rat in vivo, via the time-dependent induction of miR-182/96. Additionally, we confirm that B13/H cells respond to Car activators in a typical rat-specific manner. These data suggest that the B13/H cells produce temporal responses to PB that are comparable to those reported in short-term primary rat hepatocyte cultures and in the longer term are similar to those in the rat in vivo. Finally, we also show that Car-associated miR-122 expression is decreased by PB treatment in B13/H cells, a PB-induced response that is common to the rat, mouse and human. We conclude that the B13/H cell system produces a qualitative response comparable to the rat, which is different to the response in the mouse, and that this model could be a useful tool for exploring the functional consequences of PB-sensitive miRNA changes and resistance to PB-mediated tumours in the rat.
authors.affiliation: Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.
authors.forename: M
authors.initials: M
authors.lastname: Osborne
authors.affiliation: Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.
authors.forename: M
authors.initials: M
authors.lastname: Haltalli
authors.affiliation: Syngenta, Jealott's Hill, Bracknell, Berkshire, RG42 6EY, UK.
authors.forename: R
authors.initials: R
authors.lastname: Currie
authors.affiliation: Syngenta, Jealott's Hill, Bracknell, Berkshire, RG42 6EY, UK.
authors.forename: J
authors.initials: J
authors.lastname: Wright
authors.affiliation: Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Electronic address: n.gooderham@imperial.ac.uk.
authors.forename: N J
authors.initials: NJ
authors.lastname: Gooderham
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D048049:Extracellular Signal-Regulated MAP Kinases / Q000187:drug effects / Q000378:metabolism; D022781:Hepatocytes / Q000187:drug effects*; D035683:MicroRNAs / Q000378:metabolism; D010179:Pancreas / Q000166:cytology* / Q000187:drug effects; D010634:Phenobarbital / Q000494:pharmacology*; D051057:Proto-Oncogene Proteins c-akt / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013234:Stem Cells / Q000187:drug effects*
chemical_list: D002273:Carcinogens; D035683:MicroRNAs; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases; D010634:Phenobarbital
keywords: B13/H cells; constitutive androstane receptor; cyp2b; hepatocytes; miRNA; phenobarbital